1. Home
  2. BGC vs KRYS Comparison

BGC vs KRYS Comparison

Compare BGC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGC
  • KRYS
  • Stock Information
  • Founded
  • BGC 1945
  • KRYS 2015
  • Country
  • BGC United States
  • KRYS United States
  • Employees
  • BGC N/A
  • KRYS N/A
  • Industry
  • BGC Investment Bankers/Brokers/Service
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BGC Finance
  • KRYS Health Care
  • Exchange
  • BGC Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • BGC 4.7B
  • KRYS 4.8B
  • IPO Year
  • BGC 1999
  • KRYS 2017
  • Fundamental
  • Price
  • BGC $8.92
  • KRYS $168.58
  • Analyst Decision
  • BGC Buy
  • KRYS Strong Buy
  • Analyst Count
  • BGC 1
  • KRYS 7
  • Target Price
  • BGC $12.00
  • KRYS $206.67
  • AVG Volume (30 Days)
  • BGC 3.3M
  • KRYS 243.7K
  • Earning Date
  • BGC 02-12-2025
  • KRYS 11-04-2024
  • Dividend Yield
  • BGC 0.89%
  • KRYS N/A
  • EPS Growth
  • BGC 568.68
  • KRYS N/A
  • EPS
  • BGC 0.24
  • KRYS 1.77
  • Revenue
  • BGC $2,119,639,000.00
  • KRYS $241,519,000.00
  • Revenue This Year
  • BGC $17.19
  • KRYS $485.65
  • Revenue Next Year
  • BGC $10.16
  • KRYS $58.64
  • P/E Ratio
  • BGC $36.97
  • KRYS $95.31
  • Revenue Growth
  • BGC 13.11
  • KRYS 2722.80
  • 52 Week Low
  • BGC $6.22
  • KRYS $107.50
  • 52 Week High
  • BGC $11.79
  • KRYS $219.34
  • Technical
  • Relative Strength Index (RSI)
  • BGC 32.60
  • KRYS 37.65
  • Support Level
  • BGC $8.90
  • KRYS $162.33
  • Resistance Level
  • BGC $9.20
  • KRYS $193.07
  • Average True Range (ATR)
  • BGC 0.22
  • KRYS 8.51
  • MACD
  • BGC -0.05
  • KRYS -2.74
  • Stochastic Oscillator
  • BGC 4.91
  • KRYS 10.29

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves the global financial markets, energy and commodities markets. Its service and product offerings include brokerage for a wide range of financial products including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically the company generates revenue from Asia, Other Europe/MEA, France, Other Americas with the majority of its revenue coming from United Kingdom followed by the United States.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: